Financial Statements

Sava Re

Statement of financial position

(EUR)
Notes
31/12/2018
31/12/2017
ASSETS
606,331,055
580,886,180
Intangible assets
1
892,724
807,011
Property, plant and equipment
2
2,654,540
2,485,645
Deferred tax assets
3
1,867,370
1,238,826
Investment property
4
8,285,733
8,230,878
Financial investments in subsidiaries and associates
5
220,219,086
193,409,578
Financial investments:
6
244,291,434
250,781,685
- loans and deposits
10,107,498
12,840,885
- held to maturity
2,075,425
2,075,111
- available for sale
228,151,616
235,456,116
- at fair value through profit or loss
3,956,895
409,573
Reinsurers’ share of technical provisions
7
21,437,221
20,073,571
Receivables
8
87,830,299
88,602,395
Receivables arising out of primary insurance business
82,518,635
85,167,822
Receivables arising out of co-insurance and reinsurance business
4,842,279
3,202,926
Other receivables
469,385
231,647
Deferred acquisition costs
9
7,821,932
7,778,499
Other assets
10
379,264
799,634
Cash and cash equivalents
11
10,651,452
6,678,458
EQUITY AND LIABILITIES
606,331,055
580,886,180
Equity
319,355,361
290,966,155
Share capital
12
71,856,376
71,856,376
Capital reserves
13
54,239,757
54,239,757
Profit reserves
14
184,424,862
163,491,114
Own shares
15
-24,938,709
-24,938,709
Fair value reserve
16
2,697,381
3,804,764
Reserve due to fair value revaluation
40,772
13,524
Retained earnings
17
10,101,172
6,012,233
Net profit or loss for the period
17
20,933,749
16,487,096
Technical provisions
18
234,173,078
232,639,163
Unearned premiums
47,147,505
47,602,457
Provision for outstanding claims
185,988,628
184,269,492
Other technical provisions
1,036,945
767,214
Other provisions
19
376,521
351,250
Other financial liabilities
10
87,504
91,182
Liabilities from operating activities
20
49,185,680
54,404,921
Liabilities from primary insurance business
44,039,129
51,160,114
Liabilities from reinsurance and co-insurance business
3,149,394
3,090,008
Current income tax liabilities
1,997,157
154,799
Other liabilities
21
3,152,911
2,433,509
The notes to the financial statements in sections 23.2–23.10 form an integral part of these financial statements.